Featured2 years ago
Organicell Regenerative Medicine Inc (OTCMKTS: OCEL) Heating Up as Biotech Prepares for its Phase I/II Randomized, Double Blinded, Placebo Trial for Zofin
Organicell Regenerative Medicine Inc (OTCMKTS: OCEL) is making an explosive move up the charts after the Company announced the Mayo Clinic will be the site for...